Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach

• Shuaibing Liu,
• Ziteng Wang,
• Xin Tian,
• Weimin Cai

Affiliations

Shuaibing Liu

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Ziteng Wang

Department of ClinicalPharmacy, School of Pharmacy, Fudan University, Shanghai, China

Xin Tian

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Weimin Cai

Department of ClinicalPharmacy, School of Pharmacy, Fudan University, Shanghai, China